Abstract
Thiostrepton is a potent antibiotic against a broad range of Gram-positive bacteria, but its medical applications have been limited by its poor aqueous solubility. In this work, the first C(sp2)─H amidation of dehydroalanine (Dha) residues was applied to the site selective modification of thiostrepton to prepare a variety of derivatives. Unlike all prior methods for the modification of thiostrepton, the alkene framework of the Dha residue is preserved and with complete selectivity for the Z-stereoisomer. Additionally, an aldehyde group was introduced by C─H amidation, enabling oxime ligation for the installation of an even greater range of functionality. The thiostrepton derivatives generally maintain antimicrobial activity, and importantly, eight of the derivatives displayed improved aqueous solubility (up to 28-fold), thereby addressing a key shortcoming of this antibiotic. The exceptional functional group compatibility and site selectivity of Co(III)-catalyzed C(sp2)─H Dha amidation suggests that this approach could be generalized to other natural products and biopolymers containing Dha residues.
Keywords: C─H activation, cobalt, antibiotic, chemoselectivity, natural product
Graphical Abstract

Co(III)-catalyzed C─H amidation was used for the site-selective modification of the antibiotic thiostrepton. A range of amide groups was installed with 1,4,2-dioxazolone coupling partners. The introduction of an aldehyde group by C─H amidation enabled modular incorporation of additional functionality by oxime formation. A number of the thiostrepton derivatives showed greatly improved aqueous solubility while maintaining antibacterial activity.
Introduction
Thiostrepton 1 (Figure 1, top) is a potent antibiotic synthesized by several strains of Gram-positive microbes.1,2 Although it is used as an active component in topical veterinary antibiotics, applications to human medicine are limited owing to poor physicochemical properties, particularly low aqueous solubility.1a Although site-specific modification of 1 is a possible approach for improving its aqueous solubility, architectural complexity and a high density of delicate functionalities provide a formidable barrier to successful, site-selective chemical modification.3,4
Figure 1.
Thiostrepton 1 and applicability of Dha residues as scaffolds for analog synthesis.
The dehydroalanine (Dha) residues characteristic of 1 and other thiopeptides are reactive sites, most notably as Michael acceptors for a variety of nucleophilic species.5 Previously, several studies have been carried out on additions to the Dha residues in 1 (Figure 1, middle).6,7 Variable Dha site selectivity was observed depending on the transformation and reaction conditions, with notable site and diastereoselectivity achieved for Rh-catalyzed arylboronic acid additions.6b Importantly, many of the synthesized thiostrepton derivatives maintained potent antibacterial activity with only moderate reductions relative to 1. However, hydrophobic functionality has generally been introduced, including in recent work involving cycloaddition to the Dha residues,7a and aqueous solubility has not been reported for any of these derivatives of 1. Moreover, physicochemical properties of derivatives of 1 have not been characterized, except for studies by Honek and coworkers on several thiol Michael adducts showing qualitative increases in overall polarity by RP-HPLC and improvements in theoretical logP.6d
The previously investigated chemical modifications of the Dhas in 1 resulted in loss of the alkene framework to give modified residues with sp3 rather than sp2 hybridization. We sought a complementary method that instead maintains the unsaturated character of the Dha residue through catalytic C(sp2)─H functionalization.8 This type of modification also avoids epimeric mixtures that can complicate isolation of pure stereoisomers for biological studies. We specifically pursued methods to install polar functionality that would be beneficial to aqueous solubility. Evaluation of a number of catalysts and coupling partners was required to achieve this goal.
Here we report the first application of C(sp2)─H amidation of Dhas for the site selective introduction of amide functionality at the terminal Dha residue of 1 (Dha1; Figure 1, bottom). In addition to defining a new threshold for functional group tolerance in Cp*Co(III)-catalyzed C─H functionalization reactions, a wide range of functionality could be incorporated by C─H amidation using dioxazolone coupling partners. Moreover, by introducing an aldehyde group with C─H amidation, oxime ligation could be employed to install an even greater range of functionality. Many of the analogs maintained potent antibacterial activity with only a moderate reduction relative to thiostrepton perhaps because Dha1 is located in a solvent exposed region of thiostrepton with modifications to this region generally well-tolerated.6b-d,7a Most importantly, many analogs showed significantly greater solubility in pH 7.2 aqueous solution with up to 28-fold improvement to 83 μg/mL, surpassing the aqueous solubility of all previously reported thiostrepton derivatives prepared by semisynthetic or biosynthetic methods.2
Results and Discussion
For C(sp2)─H functionalization of the Dhas of 1, we evaluated a range of coupling partners, including isocyanates9 and electrophilic alkenes such as enones,8 acrylates, and maleimides.10 Unfortunately, under a variety of conditions and with different transition metal catalysts, little to no desired products were obtained, often with significant degradation of the natural product. Relevant to these studies, thiostrepton completely degraded in the presence of Cu(OAc)2 or AgOAc, stoichiometric oxidants that are commonly used in C─H functionalization reactions.
We then directed our attention to 1,4,2-dioxazolones as potential amidation reagents. Chang and coworkers initially demonstrated that these reagents are particularly effective coupling partners for C─H amidation,11 and they have since been employed by many research labs for a range of different applications.12 We hypothesized that due to the inherently polar character of amide functionality, selective C─H amidation of Dha C(sp2)─H bonds could provide new analogs of thiostrepton with improved aqueous solubility. Significantly, β-amidated Dhas are found in stable bioactive natural products, suggesting that the amidated thiostrepton analogs would also be stable.13
While C(sp2)─H amidation of Dha residues have not previously been reported, structurally, Dhas bear aspects of both acrylamides and enamides, motifs that have been modified by C(sp2)─H functionalization. Specifically, Li and co-workers had shown that N-methoxyacrylamides were viable substrates for C─H amidations with dioxazolones.12i Although the C(sp2)─H amidation of enamides has not been reported, we had previously found that enamides are effective substrates for other types of C(sp2)─H functionalization under mild conditions.14
An optimized reaction system with 10 equiv of 3-phenyl-1,4,2-dioxazolone and 50 mol % of [Cp*Co(MeCN)3][SbF6]215 proved to be effective for conversion of 1 to amidation products. A 71% overall yield of amidated derivatives of 1 was obtained in 9:1 solvent mixture of 1,2-DCE/TFE based on crude UPLC analysis (Figure 2B, entry 1, see Table 1).16 Dha1 was determined to be the predominant site for C─H amidation as determined by NMR analysis (see Supporting Information). A mixed solvent system was found to be important for the desired reactivity; neat fluorinated alcohols such as HFIP led to consumption of 1 without detection of products by UPLC (entry 2). Negligible conversions were observed with 1,2-DCE and 1,4-dioxane as solvents owing to insolubility of 1 and the Co catalyst in those solvents, respectively (entries 3-4). Other mixed solvent systems allowed for significant product formation, but in lower yields relative to the DCE/TFE system (compare entry 1 with entries 5-6).
Figure 2.
Optimization of reaction conditions for thiostrepton C─H amidation. (a) Reaction scheme and generated regioisomers. (b) Conditions screened for C─H amidation. (c) Crude UPLC chromatogram for optimized conditions (entry 8).
Table 1.
Aqueous solubility of thiostrepton derivatives.
| Entry | Compound | Solubility (μg/mL)[a] |
|---|---|---|
| 1 | 1 | 3.0 ± 0.2 |
| 2 | 2a | <1.0 |
| 3 | 2c | <1.0 |
| 4 | 2e | 1.1 ± 0.2 |
| 5 | 2g | 83 ± 5 |
| 6 | 2h | <1.0 |
| 7 | 2i | 16.2 ± 0.6 |
| 8 | 2j | 22 ± 2 |
| 9 | 2k | 28 ± 4 |
| 10 | 2l | 19 ± 1 |
| 11 | 5a | <1.0 |
| 12 | 5b | <1.0 |
| 13 | 5c | 20 ± 1 |
| 14 | 5e | 1.4 ± 0.4 |
| 15 | 5f | 4.3 ± 0.4 |
| 16 | 5g | 11 ± 1 |
Bolded entries indicate improvements in solubility relative to 1.
Aqueous concentration after 24 h stirring in 10 mM aqueous MOPS buffer (average of two measurements).
Upon determination of optimal solvent conditions, we further evaluated the importance of other components of the reaction system. Minimal conversion to product occurred at 25 °C (Figure 2B, entry 7). No loss in yield was observed upon lowering the dioxazolone loading to 5 equivalents (entry 8), but the yield was reduced when 2 equivalents of the amidating agent was used (entry 9). Finally, the importance of the Co catalyst and its loading amount was established through use of an analogous Rh catalyst as well as a 10% loading of the Co catalyst, with both reactions showing negligible conversion of 1 (entries 10-11). Relatively high catalyst loading is needed likely due to sequestration by the plethora of functionalities within 1; however, the use of an earth abundant cobalt catalyst diminishes concern about this higher loading, and product purification was unimpeded by the presence of somewhat higher catalyst concentration.
With effective C─H amidation conditions in hand, we next evaluated a broader set of dioxazolone substrates for derivatization of 1 (Scheme 1). In addition to the phenyl substituent used for reaction optimization (vide supra), anisole (2b) and halobenzene (2c-d) substituents were readily installed with moderate yields and regioselectivities. Although an inductively-withdrawing CF3 group at the para position gave only trace amount of 2e, electron withdrawing substituents at the meta-position of the phenyl ring were tolerated, as exemplified by analog 2f with the meta-acetyl group. The method also enabled the introduction of nonaromatic amide groups; analogs containing alkyl chains (2g-i) and a tethered ester (2j) could be effectively synthesized with respectable yields and regioselectivities. Furthermore, MOM and MEM ethers (2k-l) were incorporated to give the respective ether-substituted amides with superb regioselectivities.
Scheme 1.
Scope of thiostrepton C─H amidation.
Having demonstrated the ability to synthesize analogs of 1 through mild, single-step C─H amidation, we then explored the potential of these analogs to serve as platforms for the modular introduction of additional functionality. Carbonyl groups are known handles for bioorthogonal oxime formation to enable a broad range of applications, including alteration of physicochemical properties and drug targeting.17 However, standard conditions for oxime formation from ketone-containing peptides17 caused extensive degradation of the thiostrepton derivative 2f appended with a ketone. We therefore explored alternate strategies for oxime synthesis that might be more compatible with the delicate nature of thiosteptron.
We expected the greater reactivity of aldehydes relative to ketones to enable oxime formation under milder conditions, and to that end we synthesized dioxazolone 4. Amidation of 1 with 4 generated crude mixtures that could be immediately used for oxime formation with an assortment of O-substituted hydroxylamines (Scheme 2). In addition to the synthesis of O-methyl oxime (5a) and hydroxime (5b) analogs, oxime tethering proved competent for the installation of various unprotected protic functionalities. Carboxylic acids (5c-d) and an alcohol (5e) were introduced in moderate yields over two steps, as determined by UPLC. A PEG3 chain was also appended to thiostrepton by the amidation-condensation sequence (5f). Finally, synthesis of 5g demonstrated that even unprotected glycosyl units could be introduced.
Scheme 2.
Oxime synthesis from a C─H amidation-condensation sequence.
We next evaluated the effects of the pendant amide substituents at Dha1 on the aqueous solubility of thiostrepton derivatives (Table 1). The thermodynamic solubility of 1 was first assessed in 10 mM aqueous MOPS buffer (pH 7.2) and was found to be 3.0 ± 0.2 μg/mL (see Supplemental Information for details). Products 2g and 2i-2l each showed substantial improvements in solubility, with 2g giving the highest solubility (83 ± 5 μg/mL; 28-fold increase). The benzamide derivatives 2a, 2c, and 2e showed poor solubilities below detection limits on UPLC, indicating that an aromatic ring was a poor fit for improving solubility as a key pharmacokinetic parameter, likely owing to an overall enhancement of lipophilic character relative to 1. Although oxime derivatives 4a-b and 4e also showed an overall reduction in aqueous solubility, the polar groups of 4c (carboxylic acid), 4f (PEG), and 4g (hexose) successfully compensated for the lipophilic aryl ring to effect substantial improvements in solubility relative to 1.
Given the large size of thiostrepton, it is somewhat surprising that a wide range of solubilities were observed for the thiostrepton derivatives. The site-specific modification of a solvent-exposed Dha site was perhaps important for achieving pronounced effects on solubility. These results validate C─H amidation as a potential tool for improving physicochemical properties of bioactive molecules, such as solubility in the case of 1.
Site-specific modification in the tail region of thiostrepton should also likely beneficial for maintaining antibacterial activity. X-ray structural determination of thiostrepton bound to the 50S ribosomal subunit have established that the tail region is solvent exposed,18 with modifications to this region generally well tolerated.6b-d,7a Analogs 2a-l and 4a-g were consequently evaluated for activity against a broad spectrum of Gram-positive bacteria (Table 2). Many analogs demonstrated activity within 2-5 times the MICs observed for 1 (Table 2, bolded entries). Importantly, except for 4g, all compounds were generally competitive with vancomycin, a potent compound currently used for treating bacterial infections.19 Only VSE E. faecium showed consistent vulnerability to vancomycin over the derivatives of 1. The most active analogs, including 2c, 4a, and 4c, possessed relatively nonpolar amides. In contrast, compounds with the smallest alkyl (2g-h) or a polar carbohydrate group (4g) had the poorest activity.
Table 2.
Antibacterial activity of 1 and derivatives.
| MIC (μg/mL) for Gram-positive organisms | ||||||||
|---|---|---|---|---|---|---|---|---|
| Compound |
S. aureus (MSSA) |
S. aureus (MRSA) |
E. faecalis (VSE) |
E. faecalis (VRE) |
E. faecium (VSE) |
E. faecium (VRE) |
S. pneumoniae | S. pyogenes |
| 1 | 0.06 | 0.12 | 0.12 | 0.12 | 0.12 | 0.06 | <0.001 | <0.001 |
| 2b | 1 | 2 | 1 | 1 | 0.5 | 0.5 | 0.008 | 0.002 |
| 2b | 1 | 2 | 2 | 1 | 1 | 1 | 0.004 | 0.004 |
| 2c | 0.25 | 0.5 | 0.25 | 0.25 | 0.25 | 0.12 | <0.001 | 0.002 |
| 2d | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | <0.001 | <0.001 |
| 2f | 1 | 2 | 1 | 1 | 1 | 0.5 | 0.004 | 0.004 |
| 2g | 2 | 4 | 4 | 4 | 4 | 2 | 0.06 | 0.06 |
| 2h | 2 | 4 | 4 | 4 | 4 | 2 | 0.06 | 0.06 |
| 2i | 0.5 | 0.5 | 0.5 | 1 | 1 | 0.25 | 0.004 | 0.004 |
| 2k | 0.5 | 1 | 1 | 1 | 1 | 0.5 | 0.015 | 0.008 |
| 2l | 1 | 1 | 1 | 1 | 1 | 1 | 0.015 | 0.015 |
| 5a | 0.5 | 0.5 | 0.5 | 0.25 | 0.25 | 0.25 | <0.001 | <0.001 |
| 5b | 0.5 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 0.002 | 0.004 |
| 5c | 1 | 1 | 2 | 1 | 2 | 1 | 0.015 | 0.015 |
| 5d | 1 | 1 | 2 | 1 | 1 | 1 | 0.015 | 0.015 |
| 5e | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 0.5 | 0.004 | 0.004 |
| 5f | 0.5 | 1 | 1 | 0.5 | 1 | 0.5 | 0.002 | 0.004 |
| 5g | 16 | 16 | 16 | 16 | 16 | 8 | 0.25 | 0.25 |
| vancomycin | 1 | 1 | 2 | >32 | 0.25 | >32 | 0.12 | 0.25 |
Conclusion
We have disclosed the site-selective modification of Dha1 of the natural product thiostrepton (1) by Cp*-catalyzed C─H amidation with dioxazolone coupling partners. This approach, which represents the first example of C─H functionalization of Dha residues to maintain the alkene character of the Dha residue, enabled the preparation of a number of novel analogs of 1. In addition, by using this approach to introduce a formyl group, the modular introduction of diverse functional groups by bioorthogonal oxime formation was also accomplished. Antibiotic activity was broadly maintained, and many of the derivatives showed greatly improved aqueous solubility. These results demonstrate the potential of Dha C(sp2)─H amidation for the synthesis of bioactive analogs of thiostrepton with improved physicochemical properties.
The current set of thiostrepton derivatives incorporate a variety of polar functionality, but none incorporate basic amines. Hergenrother and coworkers have recently reported that appending amines to antibiotics can result in dramatic improvements in accumulation and cytotoxicity for Gram-negative bacteria along with beneficial effects for Gram-positive bacteria.20 The preparation of derivatives of 1 that incorporate basic amines should improve aqueous solubility while maintaining and potentially improving activity against Gram-positive bacteria. These analogs could possibly even elicit activity against Gram-negative bacteria for which thiostrepton is inactive. The introduction of amine functionality will therefore be the focus of future work.
Beyond the immediate applications in thiostrepton derivatization, these first examples of Dha C(sp2)─H functionalization could feasibly be extended to other natural products as well as peptides and proteins that contain Dha residues.
Supplementary Material
Acknowledgements
Support from the NIH is gratefully acknowledged, R35GM122473 to JAE and R35GM132092 to SJM.
References
- [1](a).Bagley MC, Dale JW, Merritt EA, Xiong X, Chem. Rev 2005, 105, 685–714. [DOI] [PubMed] [Google Scholar]; (b) Just-Baringo X, Alberico F, Álvarez M, Mar. Drugs 2014, 12, 317–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].For leading references on biosynthetic methods to access thiostrepton derivatives, see:Wang X, Lin Z, Bai X, Tao J, Liu W, Org. Chem. Front 2019, 6, 1194–1199. [Google Scholar]
- [3].Shugrue CR, Miller SJ, Chem. Rev 2017, 117, 11894–11951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].For leading references on the total synthesis of thiostrepton, see: Nicolaou KC, Angew. Chem., Int. Ed 2012, 51, 12414–12436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].For leading references on the chemical functionalization of Dha residues, see: (a) Bogart JW, Bowers AA, Org. Biomol. Chem 2019, 17, 3653–3669. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Dadová J, Galan SRG, Davis BG, Curr. Opin. Chem. Biol 2018, 46, 71–81. [DOI] [PubMed] [Google Scholar]; (c) Cox CL, Tietz JI, Sokolowski K, Melby JO, Doroghazi JR, Mitchell DA, ACS Chem. Biol 2014, 9, 2014–2022. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Naidu BN, Li W, Sorenson ME, Connolly TP, Wichtowski JA, Zhang Y, Kim OK, Matiskella JD, Lam KS, Bronson JJ, Ueda Y, Tetrahedron Lett. 2004, 45, 1059–1063. [DOI] [PubMed] [Google Scholar]; (e) Zhu Y, van der Donk W, Org. Lett 2001, 38, 1189–1192. [DOI] [PubMed] [Google Scholar]
- [6].For conjugate additions to Dha residues in thiostrepton, see:(a) Brandhofer T, Mancheño OG, ChemCatChem. 2019, 11, 3797–3801. [Google Scholar]; (b) Key HM, Miller SJ, J. Am. Chem. Soc 2017, 139, 15460–15466. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Jonker HRA, Baumann S, Wolf A, Schoof S, Hiller F, Schulte KW, Kirschner KN, Schwalbe H, Arndt HD, Angew. Chem., Int. Ed 2011, 50, 3308–3312. [DOI] [PubMed] [Google Scholar]; (d) Myers CL, Hang PC, Ng G, Yuen J, Honek JF, Bioorg. Med. Chem 2010, 18, 4231–4237. [DOI] [PubMed] [Google Scholar]
- [7].For functionalizations of thiostrepton not involving conjugate addition, see: (a) De Vries RH, Viel JH, Oudshoorn R, Kuipers OP, Roelfs G, Chem. Eur. J 2019, 25, 12698–12702. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Gruppi F, Xu X, Zhang B, Tang JA, Jershow A, Canary JW, Angew. Chem. Int. Ed 2012, 51, 11787–11790. [DOI] [PubMed] [Google Scholar]
- [8].For leading references on the C─H functionalization of peptides, see: (a) Lorion MM, Kaplaneris N, Son J, Kuniyil R, Ackermann L, Angew. Chem. Int. Ed 2019, 58, 1684–1688. [DOI] [PubMed] [Google Scholar]; (b) Schischko A, Kaplaneris N, Rogge T, Sirvinskaite G, Son J, Ackermann L, Nat. Commun 2019, 10.1038/s41467-019-11395-3. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Zhang X, Lu G, Sun M, Mahankali M, Ma Y, Zhang M, Hua W, Hu Y, Wang Q, Chen J, He G, Qi X, Shen W, Liu P, Chen G, Nat. Chem 2018, 10, 540–548. [DOI] [PubMed] [Google Scholar]; (d) For a review, see; Wang W, Lorion MM, Shah J, Kapdi AR, Ackermann L, Angew. Chem. Int. Ed 2018, 57, 14700 – 14717. [DOI] [PubMed] [Google Scholar]
- [9].For leading references on additions to isocyanates, see: Hummel JR, Boerth JA, Ellman JA, Chem. Rev 2017, 117, 9163–9227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].For leading references on additions to Michael acceptors, see: Yang L, Huang HM, Chem. Rev 2015, 115, 3468–3517. [DOI] [PubMed] [Google Scholar]
- [11](a).Park Y, Jee S, Kim JG, Chang S, Org. Process Res. Dev 2015, 19, 1024–1029. [Google Scholar]; (b) Park J, Chang S, Angew. Chem., Int. Ed 2015, 54, 14103–14107. [DOI] [PubMed] [Google Scholar]; (c) Park Y, Park KT, Kim JG, Chang S, J. Am. Chem. Soc 2015, 137, 4534–4542. [DOI] [PubMed] [Google Scholar]
- [12](a).Pinkert T, Wegner T, Mondal S, Glorius F, Angew. Chem., Int. Ed 2019, 58, 15041–15045. [DOI] [PubMed] [Google Scholar]; (b) Maity S, Potter T, Ellman JA, Nat. Catal 2019, 2, 756–762. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Park Y, Chang S, Nat. Catal 2019, 2, 219–227. [Google Scholar]; (d) Wang H, Park Y, Bai Z, Chang S; He G, Chen G, J. Am. Chem. Soc 2019, 141, 7194–7201. [DOI] [PubMed] [Google Scholar]; (e) Shi H Dixon DJ, Chem. Sci 2019, 10, 3733–3737. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Knecht T, Mondal S, Ye J-H, Das M, Glorius F, Angew. Chem. Int. Ed 2019, 58, 7117–7121. [DOI] [PubMed] [Google Scholar]; (g) Lei H, Rovis T, J. Am. Chem. Soc 2019, 141, 2268–2273. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Hong SY, Park Y, Hwang Y, Kim YB, Baik M-H, Chang S, Science 359, 1016–1021. [DOI] [PubMed] [Google Scholar]; (i) Liu Y, Xie F, Jia AQ, Li X, Chem. Commun 2018, 54, 4345–4348. [DOI] [PubMed] [Google Scholar]; (j) Park Y, Kim Y, Chang S, Chem. Rev 2017, 117, 9247–9301. [DOI] [PubMed] [Google Scholar]
- [13].Barkei JJ, Kevany BM, Felnagle EA, Thomas MG, ChemBioChem. 2009, 10, 366–376.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Hesp KD, Bergman RG, Ellman JA, J. Am. Chem. Soc 2011, 133, 11430–11433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].The catalyst is readily prepared in two steps from commercially available materials, see: Boerth JA, Ellman JA, Angew. Chem. Int. Ed 2017, 56, 9976–9980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].See Section V and Table S1 of the Supporting Information for a preliminary evaluation of Dha Amidation with a simple model compound.
- [17].Kölomel DK, Kool ET, Chem. Rev 2017, 117, 10358–10376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, Spahn CMT, Fucini P, Mol. Cell 2008, 30, 26–38. [DOI] [PubMed] [Google Scholar]
- [19].Álvarez R, Cortés LEL, Molina J, Cisneros JM, Pachón J, Antimicrob Agents Chemother. 2016, 60, 2601–2609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Richter MF, Drown BS, Riley AP, Garcia A, Shirai T, Svec RL, Hergenrother PJ, Nature. 2017, 545, 299–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




